204 related articles for article (PubMed ID: 8135789)
1. Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long-Evans Tokushima Fatty = OLETF rats).
Funakoshi A; Miyasaka K; Jimi A; Kawanai T; Takata Y; Kono A
Biochem Biophys Res Commun; 1994 Mar; 199(2):482-8. PubMed ID: 8135789
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic regeneration after ethionine-induced acute pancreatitis in rats lacking pancreatic CCK-A receptor gene expression.
Sato T; Niikawa J; Usui I; Imamura T; Yoshida H; Tanaka S; Mitamura K
J Gastroenterol; 2003; 38(7):672-80. PubMed ID: 12898360
[TBL] [Abstract][Full Text] [Related]
3. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor.
Funakoshi A; Miyasaka K; Shinozaki H; Masuda M; Kawanami T; Takata Y; Kono A
Biochem Biophys Res Commun; 1995 May; 210(3):787-96. PubMed ID: 7539259
[TBL] [Abstract][Full Text] [Related]
4. Defects of cholecystokinin (CCK)-A receptor gene expression and CCK-A receptor-mediated biological functions in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Nakamura H; Kihara Y; Tashiro M; Kanagawa K; Shirohara H; Yamamoto M; Yoshikawa H; Fukumitsu K; Hirohata Y; Otsuki M
J Gastroenterol; 1998 Oct; 33(5):702-9. PubMed ID: 9773935
[TBL] [Abstract][Full Text] [Related]
5. Effect of timely insulin administration on pancreatic B-cells of Otsuka-Long-Evans-Tokushima-Fatty (OLETF) strain rats. An animal model of non-insulin dependent diabetes mellitus (NIDDM).
Ishida K; Mizuno A; Sano T; Noma Y; Shima K
Horm Metab Res; 1995 Sep; 27(9):398-402. PubMed ID: 8557237
[TBL] [Abstract][Full Text] [Related]
6. Regulation of pancreatic exocrine function in Otsuka Long-Evans Tokushima Fatty (OLETF) rats without gene expression of cholecystokinin-A receptor.
Funakoshi A; Miyasaka K; Shinozaki H; Arita Y; Nakano I; Nawata H
Intern Med; 1996 Apr; 35(4):249-56. PubMed ID: 8739776
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic endocrine dysfunction in rats not expressing the cholecystokinin-A receptor.
Funakoshi A; Miyasaka K; Kanai S; Masuda M; Yasunami Y; Nagai T; Ikeda S; Jimi A; Kawanami T; Kono A
Pancreas; 1996 Apr; 12(3):230-6. PubMed ID: 8830328
[TBL] [Abstract][Full Text] [Related]
8. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
Tachibana I; Akiyama T; Kanagawa K; Shiohara H; Furumi K; Watanabe N; Otsuki M
Am J Physiol; 1996 Apr; 270(4 Pt 1):G730-7. PubMed ID: 8928805
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
10. Adrenocortical insufficiency in Otsuka Long-Evans Tokushima Fatty rats, a type 2 diabetes mellitus model.
Noguchi S; Ohno Y; Aoki N
Metabolism; 2007 Oct; 56(10):1326-33. PubMed ID: 17884440
[TBL] [Abstract][Full Text] [Related]
11. Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene.
Miyasaka K; Kanai S; Ohta M; Kawanami T; Kono A; Funakoshi A
Neurosci Lett; 1994 Oct; 180(2):143-6. PubMed ID: 7700567
[TBL] [Abstract][Full Text] [Related]
12. Role of TGF-beta1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats.
Yoshikawa H; Kihara Y; Taguchi M; Yamaguchi T; Nakamura H; Otsuki M
Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G549-58. PubMed ID: 11842006
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
14. Neurohormonal regulation of pancreatic exocrine function in rats without gene expression of the cholecystokinin-A receptor.
Miyasaka K; Masuda M; Kawanami T; Funakoshi A
Pancreas; 1996 Apr; 12(3):272-9. PubMed ID: 8830334
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cholecystokinin in baseline and post-prandial whole body insulin sensitivity in rats.
Peitl B; Döbrönte R; Drimba L; Sári R; Varga A; Németh J; Pázmány T; Szilvássy Z
Eur J Pharmacol; 2010 Oct; 644(1-3):251-6. PubMed ID: 20624386
[TBL] [Abstract][Full Text] [Related]
16. Strain differences in myenteric neuron number and CCK1 receptor mRNA expression may account for differences in CCK induced c-Fos activation.
Gulley S; Sharma SK; Mansour M; Sullivan CN; Moran TH; Sayegh AI
Brain Res; 2005 Oct; 1058(1-2):109-19. PubMed ID: 16169531
[TBL] [Abstract][Full Text] [Related]
17. Role of cholecystokinin-A (CCK-A) receptor in pancreatic regeneration after pancreatic duct occlusion: a study in rats lacking CCK-A receptor gene expression.
Miyasaka K; Ohta M; Tateishi K; Jimi A; Funakoshi A
Pancreas; 1998 Mar; 16(2):114-23. PubMed ID: 9510132
[TBL] [Abstract][Full Text] [Related]
18. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
Jia D; Taguchi M; Otsuki M
Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cholecystokinin release and transcription in a rat without gene expression of cholecystokinin-A receptor.
Miyasaka K; Masuda M; Funakoshi A
Digestion; 1997; 58(2):104-10. PubMed ID: 9144298
[TBL] [Abstract][Full Text] [Related]
20. Otsuka Long-Evans Tokushima fatty (OLETF) rat is not a suitable animal model for the study of angiopathic diabetic retinopathy.
Matsuura T; Yamagishi S; Kodama Y; Shibata R; Ueda S; Narama I
Int J Tissue React; 2005; 27(2):59-62. PubMed ID: 16035649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
